Related Experiment Video
Updated: Apr 5, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-141 regulates the tumour suppressor DLC1 in colorectal cancer
Abstract:
Our previous study has showed that DLC1 acts as a functional tumor suppressor in colorectal cancer (CRC) cell lines. The aims of this study were to determine whether DLC1 is a target of MicroRNA (miRNA) regulation and to evaluate the role of this mechanism in CRC. By bioinformatics approach and literature, miR-141 was chosen for further study. The miR-141 mimic, miR-141 inhibitor were synthesized and transfected to Lovo cells. Cell growth was determined by MTT and in vivo models. The flow cytometric analysis for cell cycle determination and transwell assays for evaluating the cell invasion were used. Luciferase reporter assays and Western blots showed that DLC1 was a direct target of miR-141 in CRC. The expression levels of miR-141 were obviously up-regulated in CRC tissues compared to non-cancerous tissues, while DLC1 expression levels were down-regulated in a high proportion of clinical samples (14/18). In addition, correlation analyses revealed negative correlation between miR-141 levels and DLC1 expression levels in CRC tissues. MiR-141 overexpression promoted cell growth in vitro and in vivo, promoted cell cycle progression and invasion in Lovo cells. Furthermore, re-introduction of DLC-1 in miR-141-overexpressing Lovo cells decreased growth rate of cells, increase of the percentage in G0/G1 phase and decreased the number of migrating cells. In conclusion, we demonstrated that miR-141 is up-regulated in CRC and acts as a functional oncogene by targeting DLC1.
Insights
MicroRNA-141 (miR-141) promotes colorectal cancer (CRC) growth and invasion by targeting the tumor suppressor DLC1. This study reveals miR-141 as a potential oncogene in CRC, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Previous research identified DLC1 as a tumor suppressor in colorectal cancer (CRC).
- The role of microRNA (miRNA) regulation in DLC1 function within CRC remained unclear.
Purpose of the Study:
- To investigate if DLC1 is a target of miRNA regulation in CRC.
- To evaluate the functional role of the miR-141/DLC1 axis in colorectal cancer progression.
Main Methods:
- Bioinformatic analysis and literature review identified miR-141.
- In vitro studies involved transfecting Lovo cells with miR-141 mimic/inhibitor.
- Cell growth, cell cycle, invasion, and gene expression were assessed using MTT assays, flow cytometry, transwell assays, luciferase reporter assays, and Western blots.
- In vivo tumor models and analysis of clinical CRC samples were conducted.
Main Results:
- DLC1 was confirmed as a direct target of miR-141 in CRC.
- miR-141 was significantly upregulated, and DLC1 downregulated in CRC tissues, showing a negative correlation.
- miR-141 overexpression enhanced CRC cell proliferation, cell cycle progression, and invasion in vitro and in vivo.
- Restoring DLC1 expression in miR-141-overexpressing cells suppressed tumor growth and invasion.
Conclusions:
- miR-141 is upregulated in colorectal cancer and functions as an oncogene.
- The oncogenic role of miR-141 in CRC is mediated through the suppression of its target, DLC1.
- The miR-141/DLC1 pathway represents a potential therapeutic target for colorectal cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

